Literature DB >> 1741622

Mechanisms of natural resistance to human pathogenic fungi.

J W Murphy1.   

Abstract

Natural host-resistance mechanisms are essential first-line defenses against most mycotic agents; however, these defenses are often not sufficient for complete protection. The host relies on the immune responses to provide the additional antifungal activity necessary for maximum protection. In systemic mycotic diseases, the immune system must be functional to prevent the host from succumbing to the disease. Natural resistance mechanisms act together in a coordinated manner early in the disease process to either kill or prevent the fungal agent from proliferating and gaining entrance to other tissues. The early defensive measures of the natural effector mechanisms are usually sufficiently effective to provide time for the generally more effective immune defenses to develop. Together, the natural defenses and the immune defenses regulate each other through cytokine networks, and generally these systems provide the host with adequate protection against threatening mycotic agents.

Entities:  

Mesh:

Year:  1991        PMID: 1741622     DOI: 10.1146/annurev.mi.45.100191.002453

Source DB:  PubMed          Journal:  Annu Rev Microbiol        ISSN: 0066-4227            Impact factor:   15.500


  20 in total

1.  Stress-induced gene expression in Candida albicans: absence of a general stress response.

Authors:  Brice Enjalbert; André Nantel; Malcolm Whiteway
Journal:  Mol Biol Cell       Date:  2003-04       Impact factor: 4.138

2.  Isotype switching increases efficacy of antibody protection against Cryptococcus neoformans infection in mice.

Authors:  R R Yuan; G Spira; J Oh; M Paizi; A Casadevall; M D Scharff
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

3.  Prolonged infection by Fonsecaea pedrosoi after antigenic co-stimulation at different sites in experimental murine chromoblastomycosis.

Authors:  Alexandre Paulo Machado; Maria Regina Regis Silva; Olga Fischman
Journal:  Virulence       Date:  2010 Jan-Feb       Impact factor: 5.882

4.  Lymphocyte adhesion to Candida albicans.

Authors:  Christopher B Forsyth; Herbert L Mathews
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

Review 5.  Immunology of diseases associated with Malassezia species.

Authors:  H Ruth Ashbee; E Glyn V Evans
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

6.  Functional similarities and differences between Candida albicans Cdr1p and Cdr2p transporters.

Authors:  Christian Gauthier; Sandra Weber; Anne-Marie Alarco; Omar Alqawi; Roni Daoud; Elias Georges; Martine Raymond
Journal:  Antimicrob Agents Chemother       Date:  2003-05       Impact factor: 5.191

7.  Candida albicans estrogen-binding protein gene encodes an oxidoreductase that is inhibited by estradiol.

Authors:  N D Madani; P J Malloy; P Rodriguez-Pombo; A V Krishnan; D Feldman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

8.  Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection.

Authors:  J Mukherjee; L A Pirofski; M D Scharff; A Casadevall
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

9.  Glucose promotes stress resistance in the fungal pathogen Candida albicans.

Authors:  Alexandra Rodaki; Iryna M Bohovych; Brice Enjalbert; Tim Young; Frank C Odds; Neil A R Gow; Alistair J P Brown
Journal:  Mol Biol Cell       Date:  2009-09-16       Impact factor: 4.138

10.  Murine tissues exposed to cytotoxic drugs display altered patterns of Candida albicans adhesion.

Authors:  J L López-Ribot; C S McVay; W L Chaffin
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.